FDA inspection

FDA
Manufacturing

Compounder in Lilly lawsuit hit with FDA warning letter

A compounding pharmacy recently roped into Lilly’s fight against knockoff GLP-1s has landed in the FDA’s crosshairs for the second time in a year.
Fraiser Kansteiner Apr 24, 2025 8:20am
FDA

Aurobindo discloses FDA Form 483 at North Carolina inhaler plant

Apr 14, 2025 3:00pm
inspection

HHS layoffs could disrupt FDA inspections even more: report

Apr 3, 2025 10:03am
FDA

India's Aspen Biopharma Labs hit with FDA warning letter

Mar 26, 2025 1:09pm
Hengrui

FDA rejects Hengrui, Elevar's PD-1 cancer drug combo—again

Mar 21, 2025 3:25pm
FDA

Granules hit with FDA warning letter over production woes

Mar 5, 2025 8:38am